In our patient-derived xenograft models of pancreatic cancers, the overexpression of survivin is detected not only in PDX tumor tissues, using immunohistochemical analysis (Fig 1C), but also in corresponding pancreatic cancer cell lines (PPCLs), using flow cytometric analysis. Here, BIRC5 is linked to neoplasm.